|
|
||||||||
Department of Radiology, Radioisotope Division and Department of Cardiology, Fukui Prefectural Hospital, Fukui, Japan
Department of Nuclear Medicine, Kanazawa University School of Medicine, Kanazawa, Japan
Correspondence: For correspondence or reprints contact: Ichiro Matsunari, MD, Nuklearmedizinische Klinik und Poliklinik, der Technischen Universität München, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 München, Germany.
ABSTRACT
This study was performed to test the feasibility of early SPECT imaging with 99mTc-tetrofosmin with the presence of high hepatic activity. Methods: Thirteen normal volunteers were injected 600740 MBq of 99mTc-tetrofosmin at rest and were imaged at 10 min and 1 hr after injection. The SPECT images were reconstructed for 180° and 360° data. The early and delayed SPECT and anterior planar projection images were analyzed. Results: After excluding one subject because of high hepatic activity overlapping to the myocardium, 4 of 12 subjects (33%) had abnormal scans with reduced uptake in the inferior wall on the early 180° SPECT image. In contrast, only one (8%) showed equivocally reduced uptake on the 360° SPECT image. In the delayed images, all subjects had a normal 180° and 360° SPECT scan. Quantitative data showed reduced regional activities in the inferior wall on the early SPECT scan, especially in the 180° data. There were no changes in the mean anterior-to-inferior ratio in the anterior planar projection images over time, suggesting that the reduced activity in the early SPECT images reflected an artifactual effect. Conclusion: Our data indicate that it would be best to perform late imaging in patients with suspected coronary artery disease using 99mTc-tetrofosmin.
Key Words: technetium-99m-tetrofosmin myocardial SPECT liver-heart artifact
This article has been cited by other articles:
![]() |
A. Giorgetti, M. Rossi, M. Stanislao, G. Valle, P. Bertolaccini, A. Maneschi, R. Giubbini, M. L. De Rimini, M. Mazzanti, M. Cappagli, et al. Feasibility and Diagnostic Accuracy of a Gated SPECT Early-Imaging Protocol: A Multicenter Study of the Myoview Imaging Optimization Group J. Nucl. Med., October 1, 2007; 48(10): 1670 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hatada, L. M. Riou, M. Ruiz, Y. Yamamichi, A. Duatti, R. L. Lima, A. R. Goode, D. D. Watson, G. A. Beller, and D. K. Glover 99mTc-N-DBODC5, a New Myocardial Perfusion Imaging Agent with Rapid Liver Clearance: Comparison with 99mTc-Sestamibi and 99mTc-Tetrofosmin in Rats J. Nucl. Med., December 1, 2004; 45(12): 2095 - 2101. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |